RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BLASI F
Collezione AOU San Luigi di Orbassano

Items : 8

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI). in The World Allergy Organization journal / World Allergy Organ J. 2024 Dec 27;18(1):101016. doi: 10.1016/j.waojou.2024.101016. eCollection 2025

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Oriecuia C; Cardini C; Scioscia G; Brussino L; Braido F; Heffler E; Paggiaro P; Blasi F; Canonica GW; Sala I; Bagnardi V;

Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis. in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society / J Cyst Fibros. 2024 Mar;23(2):306-313. doi: 10.1016/j.jcf.2023.11.001. Epub 2023 Nov 8.

2024
AOU San Luigi di Orbassano

Dugac AV; Wege S; Verhulst S; Taccetti G; Pokojová E; Moreno RMG; Messore B; Fila L; Durieu I; Diamantea F; Burgel PR; Bourke S; Blasi F; Amorim A; Aliberti S; Gramegna A; Duff A; Southern KW; Castellani C;

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey. in ERJ open research / ERJ Open Res. 2023 Nov 13;9(6):00560-2023. doi: 10.1183/23120541.00560-2023. eCollection 2023 Nov.

2023
AOU San Luigi di Orbassano

Crimi C; Calabrese C; D'Amato M; Blasi F; Canonica GW; Guida G; Heffler E; Paggiaro P; Carpagnano GE;

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis. in Pulmonology / Pulmonology. 2023 Jul-Aug;29(4):338-341. doi: 10.1016/j.pulmoe.2022.09.009. Epub 2022 Oct 21.

2023
AOU San Luigi di Orbassano

Savi D; Gramegna A; Vicenzi M; Di Paolo M; Messore B; Palange P; Blasi F; Savi D; Gramegna A; Vicenzi M; Di Paolo M; Messore B; Palange P; Blasi F;

Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus. in The journal of allergy and clinical immunology. In practice / J Allergy Clin Immunol Pract. 2023 Dec;11(12):3629-3637. doi: 10.1016/j.jaip.2023.07.041. Epub 2023

2023
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Yacoub MR; Yang B; Varricchi G; Vianello A; Solidoro P; Senna G; Scichilone N; Scioscia G; Ridolo E; Rolo J; Ricciardi L; Pini L; Puggioni F; Passalacqua G; Patella V; Pelaia G; Parente R; Parazzini EM; Macchia L; Milanese M; Montagni M; Latorre M; Lombardi C; Foschino MP; Ferri S; Fierro V; Facciolongo NC; Di Proietto MC; Crivellaro M; et alii...

The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus. in Respiratory medicine / Respir Med. 2023 Dec;220:107455. doi: 10.1016/j.rmed.2023.107455. Epub 2023 Nov 3.

2023
AOU San Luigi di Orbassano

Gramegna A; Aliberti S; Calderazzo MA; Casciaro R; Ceruti C; Cimino G; Fabrizzi B; Lucanto C; Messore B; Pisi G; Taccetti G; Tarsia P; Blasi F; Cipolli M;

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI). in The World Allergy Organization journal / World Allergy Organ J. 2020 Sep 20;13(10):100464. doi: 10.1016/j.waojou.2020.100464. eCollection 202

2020
AOU San Luigi di Orbassano

Canonica GW; Blasi F; Paggiaro P; Senna G; Passalacqua G; Spanevello A; Aliberti S; Bagnasco D; Bonavia M; Bonini M; Brussino L; Bucca C; Caiaffa MF; Calabrese C; Camiciottoli G; Caminati M; Carpagnano GE; Caruso C; Centanni S; Conte ME; Corsico AG; Cosmi L; Costantino MT; Crimi N; D'Alò S; D'Amato M; Del Giacco S; Farsi A; Favero E; et alii...

Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. in Respiratory medicine / Respir Med. 2018 May;138:88-94. doi: 10.1016/j.rmed.2018.03.034. Epub 2018 Mar 31.

2018
AOU San Luigi di Orbassano

Blasi F; Carnovale V; Cimino G; Lucidi V; Salvatore D; Messore B; Bartezaghi M; Muscianisi E; Porpiglia PA;